J&J Unit Under Scrutiny For Alleged Off-Label Marketing
Johnson & Johnson said in a U.S. Security and Exchange Commission filing Tuesday that one of its subsidiaries has received a subpoena related to the alleged off-label marketing of its epilepsy...To view the full article, register now.
Already a subscriber? Click here to view full article